Skip to main content
ABT logo

ABT · Abbott Laboratories · Share Buybacks

Track ABT — free
$98.97 -1.98 (-1.96%)
Market Cap
$174.90B
Shares
1.74B
Volume · Sep 30 3.35M Avg daily vol (3M) 9.76M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$7,000,000,000
as of 2024-10-11 · from 10-Q (reviewed)
Remaining Authorization
$6,700,000,000
as of 2026-03-31 · from 10-Q (reviewed)
Program Utilization
4.3% $300,000,000 used of $7,000,000,000
Program Announced Authorized Remaining Runs Through
2024-10-11 $7,000,000,000 $6,700,000,000 —

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-03-31 YTD $180,000,000
2025-12-31 $893,000,000
2024-12-31 $1,295,000,000
2023-12-31 $1,227,000,000
2022-12-31 $3,795,000,000
2021-12-31 $2,299,000,000
2020-12-31 $403,000,000
2019-12-31 $718,000,000
2018-12-31 $238,000,000
2017-12-31 $117,000,000
2016-12-31 $522,000,000
2015-12-31 $2,237,000,000
2014-12-31 $2,195,000,000
2013-12-31 $1,605,000,000
2012-12-31 $2,364,000,000
2011-12-31 $77,000,000
2010-12-31 $866,825,000
2009-12-31 $826,345,000
2008-12-31 $1,081,806,000
2007-12-31 $1,058,793,000
Key facts CIK 1800 CUSIP 002824100 13F (30d) 87 filings 37 filers Visit website